These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 33909803

  • 1. LONG TERM MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B: A BRAZILIAN TERTIARY CENTER EXPERIENCE.
    Takao MMV, Sandy NS, Riccetto AGL, Tommaso AMA.
    Arq Gastroenterol; 2021; 58(1):87-92. PubMed ID: 33909803
    [Abstract] [Full Text] [Related]

  • 2. Assessment of the diagnosis, treatment, and follow-up of a group of Turkish pediatric glycogen storage disease type 1b patients with varying clinical presentations and a novel mutation.
    Küçükçongar Yavaş A, Engin Erdal A, Bilginer Gürbüz B, Ünlüsoy Aksu A, Kasapkara ÇS.
    J Pediatr Endocrinol Metab; 2023 Nov 27; 36(11):1092-1099. PubMed ID: 37791580
    [Abstract] [Full Text] [Related]

  • 3. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
    Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Groenier KH, Smit GP.
    Eur J Pediatr; 2002 Oct 27; 161 Suppl 1():S83-7. PubMed ID: 12373578
    [Abstract] [Full Text] [Related]

  • 4. Inflammatory bowel disease-like colitis in glycogen storage disease type 1b.
    Yamaguchi T, Ihara K, Matsumoto T, Tsutsumi Y, Nomura A, Ohga S, Hara T.
    Inflamm Bowel Dis; 2001 May 27; 7(2):128-32. PubMed ID: 11383585
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
    Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J.
    Blood; 2001 Jan 15; 97(2):376-82. PubMed ID: 11154211
    [Abstract] [Full Text] [Related]

  • 6. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
    Li AM, Thyagu S, Maze D, Schreiber R, Sirrs S, Stockler-Ipsiroglu S, Sutherland H, Vercauteren S, Schultz KR.
    Pediatr Hematol Oncol; 2018 Feb 15; 35(1):45-51. PubMed ID: 29652549
    [Abstract] [Full Text] [Related]

  • 7. Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b.
    Grünert SC, Gautschi M, Baker J, Boyer M, Burlina A, Casswall T, Corpeleijn W, Çıki K, Cotter M, Crushell E, Derks TGJ, Haas D, Kilavuz S, Kingma SDK, Korman SH, Kozek A, de Laet C, Mundy H, Nassogne MC, Quintero V, Rossi A, Spenger J, Spiegel R, Stephenne X, Stojkov D, Tal G, Veiga-da Cunha M, Wortmann SB.
    Mol Genet Metab; 2024 Jun 15; 142(2):108486. PubMed ID: 38733639
    [Abstract] [Full Text] [Related]

  • 8. Case report: The success of empagliflozin therapy for glycogen storage disease type 1b.
    Klinc A, Groselj U, Mlinaric M, Homan M, Markelj G, Mezek Novak A, Sirca Campa A, Sikonja J, Battelino T, Zerjav Tansek M, Drole Torkar A.
    Front Endocrinol (Lausanne); 2024 Jun 15; 15():1365700. PubMed ID: 38919482
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L.
    Pediatr Res; 1994 Jan 15; 35(1):84-90. PubMed ID: 7510873
    [Abstract] [Full Text] [Related]

  • 10. Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1.
    Visser G, Rake JP, Labrune P, Leonard JV, Moses S, Ullrich K, Wendel U, Smit GP, European Study on Glycogen Storage Disease Type I.
    Eur J Pediatr; 2002 Oct 15; 161 Suppl 1():S120-3. PubMed ID: 12373585
    [Abstract] [Full Text] [Related]

  • 11. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
    Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, Leung J, Boxer LA, Kishnani PS, Austin S, Wanner C, Ferrecchia IA, Khalaf D, Maze D, Kurtzberg J, Zeidler C, Welte K, Weinstein DA.
    Curr Opin Hematol; 2019 Jan 15; 26(1):16-21. PubMed ID: 30451720
    [Abstract] [Full Text] [Related]

  • 12. Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in Poland.
    Kaczor M, Wesół-Kucharska D, Greczan M, Kierus K, Kałużny Ł, Duś-Żuchowska M, Ehmke Vel Emczyńska-Seliga E, Ciara E, Książyk J, Rokicki D.
    Pediatr Endocrinol Diabetes Metab; 2022 Jan 15; 28(3):207-212. PubMed ID: 35620924
    [Abstract] [Full Text] [Related]

  • 13. Acute myelogenous leukemia and glycogen storage disease 1b.
    Pinsk M, Burzynski J, Yhap M, Fraser RB, Cummings B, Ste-Marie M.
    J Pediatr Hematol Oncol; 2002 Dec 15; 24(9):756-8. PubMed ID: 12468919
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human GM-CSF treatment of neutropenia in glycogen storage disease-1b.
    Hurst D, Kilpatrick L, Becker J, Lipani J, Kleman K, Perrine S, Douglas SD.
    Am J Pediatr Hematol Oncol; 1993 Feb 15; 15(1):71-6. PubMed ID: 8447561
    [Abstract] [Full Text] [Related]

  • 15. Rare complication of inflammatory bowel disease-like colitis from glycogen storage disease type 1b and its surgical management: A case report.
    Lui FC, Lo OS.
    World J Clin Cases; 2021 Jun 06; 9(16):4081-4089. PubMed ID: 34141769
    [Abstract] [Full Text] [Related]

  • 16. Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report.
    Rossi A, Miele E, Fecarotta S, Veiga-da-Cunha M, Martinelli M, Mollica C, D'Armiento M, Mozzillo E, Strisciuglio P, Derks TGJ, Staiano A, Parenti G.
    Ital J Pediatr; 2021 Jul 02; 47(1):149. PubMed ID: 34215305
    [Abstract] [Full Text] [Related]

  • 17. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey.
    Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L.
    Eur J Pediatr; 2002 Oct 02; 161 Suppl 1():S88-92. PubMed ID: 12373579
    [Abstract] [Full Text] [Related]

  • 18. Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).
    Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP.
    Eur J Pediatr; 2002 Oct 02; 161 Suppl 1():S20-34. PubMed ID: 12373567
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of Pediatric Liver Transplantation in Glycogen Storage Disease Type 1b-A Single-Center Experience.
    Rajasekaran V, Santra S, Kelgeri C, Johansen L, Vijay S, Sreekantam S, Raiman J, Daly A, Sharif K, Kitchen S, Gupte G.
    Pediatr Transplant; 2024 Nov 02; 28(7):e14839. PubMed ID: 39212088
    [Abstract] [Full Text] [Related]

  • 20. Pregnancy in glycogen storage disease type Ib: gestational care and report of first successful deliveries.
    Dagli AI, Lee PJ, Correia CE, Rodriguez C, Bhattacharya K, Steinkrauss L, Stanley CA, Weinstein DA.
    J Inherit Metab Dis; 2010 Dec 02; 33 Suppl 3(0 3):S151-7. PubMed ID: 20386986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.